Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Upload application in...

    Upload application in SUGAM as per new Rules: CDSCO issues notice

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-04-13T13:39:17+05:30  |  Updated On 13 Aug 2021 4:37 PM IST

    New Delhi: Through a recent notice, the Central Drugs Standard Control Organization (CDSCO) has informed that uploading of applications through SUGAM Portal should be in accordance with the New Drugs and Clinical Trials Rules, 2019.


    The New Drugs and Clinical Trials Rules, 2019 have been published with effect from 19.03.2019 for regulation of New Drugs, Investigational New Drugs for human use, Clinical trials, bioequivalence study, bioavailability study and Ethics Committee.


    The rules provide various Forms for submission of applications & grant of approvals of various categories of new drugs and clinical trials.


    Earlier the applications for approval of New Drugs, Investigational New Drugs for human use, Clinical trials, bioequivalence study, bioavailability study and Ethics Committee were required to be submitted as per the provisions prevalent in the Drugs and Cosmetic Rules, 1945. Applications for various categories of the new drug are submitted and processed online through SUGAM portal.


    In light of the New Drugs and Clinical Trials Rules, 2019, CDSCO brought to the notice of applicants that they should submit their application as per the relevant checklist provided in the SUGAM portal.


    The notice informed that Application Form for the specific purpose should be prepared offline in the relevant Form as per the New Drugs and Clinical Trials Rules, 2019 and a scanned copy of the same should be uploaded in the respective item provided in the checklist. The Gazette notification containing the New Drugs and Clinical Trials Rules, 2019 including the Forms is available at www.cdsco.qov.in. Necessary provisions in this regard have already been made in the SUGAM portal for the online submission of the applications.


    Similarly, the applicants are also required to submit fees as per the Sixth Schedule of New Drugs and Clinical Trials Rules, 2019 for which they are required to upload the copy of T.R. Challan or receipt of Bharat Kosh in the respective item provided in the check-list.


    For further clarification, if any, required by any stakeholders in this regard, they may contact the IT Cell of CDSCO at email it-helpdesk@cdsco.nic.in, the notice added.


    Also Read: SUGAM registration Mandatory: CDSCO directs State drugs controllers to enforce rule

    bioequivalence studyCDSCOCDSCO IT cellCentral Drugs Standard Control Organizationclinical trialsDrugs and Cosmetic Rulesgazette notificationhelpdesk@cdsco.nic.inInvestigational new drugsInvestigational New Drugs for human useIT cellnew drugsNew Drugs and Clinical Trials RulesSugamSUGAM portalwww.cdsco.qov.in

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok